This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Dulce Maria Garrido - Pioneering Agonists in Therapeutics
Introduction
Dulce Maria Garrido is an accomplished inventor based in Durham, North Carolina, whose innovative contributions to the field of therapeutics are noteworthy. With a focus on GPR40 agonists, her work exemplifies the intersection of creativity and scientific advancement in the pharmaceutical industry.
Latest Patents
Dulce Maria Garrido holds a significant patent titled "Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40". This invention pertains to novel therapeutic compounds that serve as GPR40 agonists. The patent encompasses not only the compounds themselves but also their manufacturing processes and the intermediates involved in their preparation. With a singular focus on improving therapeutic options, her work has the potential to impact various medical treatments.
Career Highlights
Garrido is affiliated with GlaxoSmithKline LLC, a leading global healthcare company. Her role within the company highlights her commitment to advancing medical research and innovation. The successful development of her patented compounds reflects her expertise and dedication in the pharmaceutical field.
Collaborations
In her career, Dulce has worked alongside esteemed colleagues, including David Francis Corbett and Kate Anna Dwornik. This collaborative environment fosters innovation and enhances the quality of research and development in which they partake. The teamwork within this group exemplifies the importance of cooperative efforts in achieving groundbreaking results in therapeutic advancements.
Conclusion
Dulce Maria Garrido's innovative work as an inventor in therapeutic sciences demonstrates her significant contribution to improving healthcare. Her patent on GPR40 agonists is just one example of her dedication to enhancing therapeutic options for various medical conditions. As she continues her work at GlaxoSmithKline LLC, her contributions will undoubtedly leave a lasting impact on the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile